Found 10 matching trials
A Study in Healthy People to Test Whether Different Doses of BI 1015550 Have Potential to Induce Heart Rhythm Abnormalities PHASE1 The main objective of this trial is to evaluate the effects of a single the...
Show More Location
Quotient Sciences
Learn More & Join Trial
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression PHASE3 This study is open to adults with fibrosing interstitial lung disease (ILD)...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies PHASE3 This study is open to adults aged 18 and older who have a condition known a...
Show More Location
Arizona Neuromuscular Research Center
Learn More & Join Trial
This Study Tests How Healthy Men Tolerate Different Doses of BI1015550. The Study Also Tests How BI 1015550 is Taken up by the Body PHASE1 Part 1 (SRD (Single-rising dose)):
The primary objective of this trial par...
Show More Location
CRS Clinical Research Services Mannheim GmbH
Learn More & Join Trial
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) PHASE3 This study is open to adults with Progressive Fibrosing Interstitial Lung D...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) PHASE3 This study is open to adults with a lung disease called Idiopathic Pulmonar...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
This Study Tests Different Doses of BI 1015550 in Patients With Idiopathic Pulmonary Fibrosis (IPF). The Study Tests How BI 1015550 is Taken up by the Body and How Well it is Tolerated. PHASE1 The primary objective is to investigate safety and tolerability of BI 10155...
Show More Location
Odense University Hospital
Learn More & Join Trial
Platform Clinical Study for Conquering Scleroderma PHASE2 The goal of this clinical trial is to test efficacy of different investigat...
Show More Location
University of Alabama - Division of Pulmonary and Critical Care Medicine
Learn More & Join Trial
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis PHASE3 Nerandomilast is being developed to help people with systemic sclerosis by ...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases PHASE3 Adults 18 years of age and older or above legal age with lung fibrosis rela...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial